Skip to main content
Home logo

User account menu

Log inSearch
  • Home
  • Data Sources
  • Studies
  • Institutions
  • Networks
  • What's new
  • Support
  1. Home

Subscribe to TK011: Prospective, non-interventional, post-authorisation safety study (PASS) of Zalmoxis prescribed in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk hematological malignancies

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Privacy policy
Cookies
Legal notice
Accessibility

Contact

Contact us